| Here are the 9 fastest-growing biotech firms in the Bay State Last year, there were nine Massachusetts-based biotech firms that grew total headcount by at least 40 percent. The Bay State’s next commercial drugmaker targets Andre the Giant's disease The worldwide market is about $750 million, and the company plans to price its treatment “to be competitive” with existing drugs, which cost between $45,000 and $65,000 a year. This MIT-born startup could help the White House find a cure for cancer When executives at MIT-born big data startup Tamr heard about Vice President Joe Biden's initiative to accelerate the fight against cancer, they were intrigued. Harvard gets approval to build new Life Lab in Allston At its March board meeting, the Boston Redevelopment Authority approved seven projects 637,596 square feet and representing a total of $258.6 million in development costs. | 
